LeMaitre Vascular Announces Q4 2018 Financial Results

Go back to LeMaitre Vascular Announces Q4 2018 Financial Results

Lemaitre Vascular (LMAT) Tops Q4 EPS by 10c, Offers Guidance

February 19, 2019 4:07 PM EST

Lemaitre Vascular (NASDAQ: LMAT) reported Q4 EPS of $0.30, $0.10 better than the analyst estimate of $0.20. Revenue for the quarter came in at $28.4 million versus the consensus estimate of $25.91 million.

GUIDANCE:

Lemaitre Vascular sees Q1 2019 EPS of $0.18-$0.20, versus the consensus of $0.20.... More